Anticonvulsants

  • Robert J. DeLorenzo
  • Larry H. Dashefsky

Abstract

Anticonvulsant compounds are widely used to treat and manage epilepsy in man. Epilepsy is defined as the tendency to experience recurrent seizures of major or minor intensity and characteristics.1 This condition is one of the most common afflictions of man, affecting at least 1% of any general population.2 Thus, anticonvulsant drugs represent a commonly used and neuropharmacologically important class of clinically effective compounds.

Keywords

Status Epilepticus Antiepileptic Drug Sodium Valproate Anticonvulsant Effect Seizure Threshold 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Glaser, G. H., 1981, Clinical Medicine, Volume 11 (J. A. Spittell, Jr., ed.), Harper and Row, New York, pp. 1–26.Google Scholar
  2. 2.
    Glaser, G. H., 1978, J. Nerv. Ment. Dis. 166: 268–274.PubMedGoogle Scholar
  3. 3.
    Glaser, G. H., Penry, J. K., and Woodbury, D. W., 1980, Antiepileptic Drugs: Mechanisms of Action, Raven Press, New York.Google Scholar
  4. 4.
    Woodbury, D. M., Penry, J. K., and Pippenger, C. E., 1982, Antiepileptic Drugs, Second ed., Raven Press, New York.Google Scholar
  5. 5.
    Purpura, D. P., Penry, J. K., Tower, D., Woodbury, D. M., and Walter, R., 1982, Experimental Models of Epilepsy—A Manual for the Laboratory Worker, Raven Press, New York.Google Scholar
  6. 6.
    Hippocrates, 1849, The Genuine Works (R Adams, transi.), William Wood, New York.Google Scholar
  7. 7.
    The New English Bible, New Testament,Oxford and Cambridge University Presses, London, 1961, Matthew 17:15–18.Google Scholar
  8. 8.
    Temkin, O., 1971, The Falling Sickness, 2nd ed., Johns Hopkins University Press, Baltimore.Google Scholar
  9. 9.
    Jackson, J. H., 1931, On Epilepsy and Epileptiform Convulsions, Volume 1, Hodder and Stoughton, London.Google Scholar
  10. 10.
    Locock, C., 1957, Lancet 1: 527.Google Scholar
  11. 11.
    Hauptmann, A., 1912, Munch. Med. Wochenschr. 59: 1907–1909.Google Scholar
  12. 12.
    Weese, H., 1932, Deut. Med. Wochenschr. 58: 696.Google Scholar
  13. 13.
    Swinyard, E. A., 1980, Antiepileptic Drugs: Mechanisms of Action (G. H. Glaser, J. K. Penry, and D. M. Woodbury, eds.), Raven Press, New York, pp. 1–9.Google Scholar
  14. 14.
    Marce, M., 1964, C.R. Acad. Sci. [D] (Paris) 58: 628–629.Google Scholar
  15. 15.
    Fritsch, G., and Hitzig, E., 1870, Arch. Anat. Physiol. Wiss. Med. 37: 300–332.Google Scholar
  16. 16.
    Browne, J. C., 1875, Br. Med. J. 1: 409–411.PubMedGoogle Scholar
  17. 17.
    Albertoni, P., 1832, Arch. Exp. Pathol. Pharmacol. 15: 248–288.Google Scholar
  18. 18.
    Schilf, E.. 1922, Z. Ges. Exp. 28: 127.Google Scholar
  19. 19.
    Spiegel, E. A., 1937, J. Lab. Clin. Med. 22: 1274–1276.Google Scholar
  20. 20.
    Putnam, T. J., and Merritt, H. H., 1937, Science 85: 525–526.PubMedGoogle Scholar
  21. 21.
    Merritt, H. H., and Putnam, T. J., 1938, J.A.M.A. 111: 1068–1073.Google Scholar
  22. 22.
    Hildebrandt, F., 1926, Arch. Pharmacol. 1168: 100–116.Google Scholar
  23. 23.
    Everett, G. M., and Richards, R. K., 1944, J. Pharmacol. Exp. Ther. 81: 402–407.Google Scholar
  24. 24.
    Richards, R. K., and Everett, G. M., 1944, Fed. Proc. 3: 39.Google Scholar
  25. 25.
    Goodman, L. S., and Manuel, C., 1945, Fed. Proc. 4: 119.Google Scholar
  26. 26.
    Goodman, L. S., Swinyard, E. A., and Toman, J. E. P., 1945, Proc. Am. Fed. Clin. Res. 2: 100–101.PubMedGoogle Scholar
  27. 27.
    Toman, J. E. P., Loewe, S., and Goodman, L. S., 1947, Arch. Neurol. Psychiatry 58: 31 2324.Google Scholar
  28. 28.
    Toman, J. E. P., Swinyard, E. A., and Goodman. L. S., 1946, J. Neurophysiol. 9: 231–239.PubMedGoogle Scholar
  29. 29.
    Wada, J. A., 1977, Arch. Neurol. 34: 389–395.PubMedGoogle Scholar
  30. 30.
    Watson, E. L., and Woodbury, D. M., 1972, J. Pharmacol. Exp. Ther. 180: 767–776.PubMedGoogle Scholar
  31. 31.
    Johnston, D., and Ayala, G. F., 1975, Science 189: 1009–1011.PubMedGoogle Scholar
  32. 32.
    Bogue, J. Y., and Carrington, H. C., 1953, Br. J. Pharmocol. 8: 230–236.Google Scholar
  33. 33.
    Prichard, J. W., 1982, Antiepileptic Drugs (D. M. Woodbury, J. K. Penry, and C. E. Pippenger, eds.), Second ed., Raven Press, New York, pp. 365–376.Google Scholar
  34. 34.
    Gastaut, H., Roger, J., and Lob, H., 1973, Anticonvulsant Drugs, Volume 2 (J. Mercier, ed.), Pergamon Press, Oxford, pp. 535–598.Google Scholar
  35. 35.
    Millichap, J. G., 1973, Anticonvulsant Drugs (J. Mercier, ed.), Pergamon Press, Oxford, pp. 180–202.Google Scholar
  36. 36.
    Aird, R. B., and Woodbury, D. M., 1974, The Management of Epilepsy, Charles C Thomas, Springfield, Illinois.Google Scholar
  37. 37.
    Woodbury, D. M., 1980, Antiepileptic Drugs: Mechanisms of Action (G. H. Glaser, J. K. Penry, and D. M. Woodbury, eds.), Raven Press, New York, pp. 249–305.Google Scholar
  38. 38.
    Vida, J. A., and Gerry, E. H., 1977, Anticonvulsants (J. A. Vida, ed.), Academic Press, New York, pp. 152–176.Google Scholar
  39. 39.
    Johannesan, S. I., 1982, Antiepileptic Drugs, Second ed., ( D. M. Woodbury, J. K. Penry, and C. E. Pippenger, eds.). Raven Press, New York, pp. 297–308.Google Scholar
  40. 40.
    Schafer, H. R., 1982, Antiepileptic Drugs, Second ed., (D. M. Woodbury, J. K. Penry, and C. E. Pippenger, eds.), Raven Press, New York, pp. 395–404.Google Scholar
  41. 41.
    Booker, H. E., 1982, Antiepileptic Drugs, Second ed., ( D. M. Woodbury, J. K. Penry, and C. E. Pippenger, eds.), Raven Press, New York. pp. 341–350.Google Scholar
  42. 42.
    Harvey, S. C., 1980, The Pharmacologic Basis of Therapeutics, Sixth ed. ( A. G. Goodman, L. S. Goodman, and A. Gilman, eds.), Macmillan, New York, pp. 339–375.Google Scholar
  43. 43.
    Kay, D. C., Jasinski, D. R., and Eisenstein, R. B., 1972, Clin. Pharmacol. Ther. 13: 221–241.PubMedGoogle Scholar
  44. 44.
    Oswald, I., and Priest, R. G.. 1965, Br. filed. J. 2: 1093–1099.Google Scholar
  45. 45.
    Gallagher, B. B., Smith, D. B., and Mattson, R. H., 1970, Epilepsia 11: 293–301.PubMedGoogle Scholar
  46. 46.
    Gallagher, B. B., 1977, Anticonvulsants (J. A. Vida, ed.), Academic Press, New York, pp. 11–55.Google Scholar
  47. 47.
    Wada, J. A., 1976, Kindling, Raven Press, New York.Google Scholar
  48. 48.
    Albertson, T. E., Peterson, S. L., and Stark, L. G., 1978, Exp. Neurol. 61: 270–276.PubMedGoogle Scholar
  49. 49.
    Woodbury, D. M., and Pippenger, C. E., 1982, Antiepileptic Drugs, Second ed. (D. M. Woodbury, J. K. Penry, and C. E. Pippenger, eds.), Raven Press, New York, pp. 444 452.Google Scholar
  50. 50.
    Reinhard, J. F., and Reinhard. J. F., Jr. 1977, Anticonvulsant (J. A. Vida, ed.), Academic Press, New York, pp. 57–11l.Google Scholar
  51. 51.
    Gallagher, B. B., Baumiel, I. P., Woodbury, S. G., and DiMicco, J. A., 1975, Neurology (Minneap.) 25: 399–404.Google Scholar
  52. 52.
    Essig, C. F., 1972, Experimental Models of Epilepsy (D. P. Purpura, J. K. Penry, D. B. Tower, D. M. Woodbury, and R. D. Walter, eds.), Raven Press, New York, pp. 495–508.Google Scholar
  53. 53.
    Mattson, R. H., and Cramer, J. A., 1982, Antiepileptic Drugs, Second ed. ( D. M. Woodbury, J. K. Penry, and C. E. Pippenger, eds.), Raven Press, New York, pp. 351–364.Google Scholar
  54. 54.
    Rosner, B. S., and Clark, D. L., 1973, Anesthesiology 39: 59–81.Google Scholar
  55. 55.
    Prichard, J. W., 1980, Antiepileptic Drugs: Mechanisms of Action (G. H. Glaser, J. K. Penry, and D. M. Woodbury, eds.), Raven Press, New York, pp. 553–562.Google Scholar
  56. 56.
    Esplin, D. W., 1972, Experimental Models of Epilepsy (D. P. Purpura, J. K. Penry, D. B. Tower, D. M. Woodbury, and R. D. Walter, eds.), Raven Press, New York, pp. 223–248.Google Scholar
  57. 57.
    Sohn, R. S., and Ferrendelli, J. A., 1976. Arch. Neurol. 33: 626–629.PubMedGoogle Scholar
  58. 58.
    Richens, A., 1976. Drug Treatment of Epilepsy, Kimptom, London.Google Scholar
  59. 59.
    Richens, A., and Woodford, F. P., 1976, Anticonvulsant Drugs and Enzyme Induction, Excerpta Medica, Amsterdam.Google Scholar
  60. 60.
    Reynolds, E. H., Lancet 1 :1376–1378.Google Scholar
  61. 61.
    Maynert, E. W., 1982, Antiepileptic Drugs, Second ed. ( D. M. Woodbury, J. K. Penry, and C. E. Pippenger, eds.), Raven Press, New York, pp. 309–318.Google Scholar
  62. 62.
    Whyte, M. P., and Dekaban, A. S., 1977, Drug. Metab. Dispos. 5: 63.PubMedGoogle Scholar
  63. 63.
    Eadie, M. J., 1982, Antiepileptic Drugs, Second ed. ( D. M. Woodbury, J. K. Penry, and C. E. Pippenger, eds.), Raven Press, New York, pp. 377–395.Google Scholar
  64. 64.
    Wadell, W. J., and Butler, T. C., 1957, J. Clin. Invest. 36: 1217–1226.Google Scholar
  65. 65.
    Goldberg, M. A., 1980, Antiepileptic Drugs: Mechanisms of Action (G. H. Glaser, J. K. Penry, and D. M. Woodbury, eds.), Raven Press, New York, pp. 501–504.Google Scholar
  66. 66.
    Donuh, N. S., Barlow, C. F., and Roth, L. S., 1960, J. Pharmacol. Exp. Ther. 130: 285–293.Google Scholar
  67. 67.
    Penry, J. K., and Newmark, M. E., 1979, Ann. Intern. Med. 90: 207–218.PubMedGoogle Scholar
  68. 68.
    Brodie, B. B., Kurz, H., and Scharber, L. S., 1960, J. Pharmacol. Exp. Ther. 130: 20–25.PubMedGoogle Scholar
  69. 69.
    Schottelius, D. D., 1982, Antiepileptic Drugs, Second ed. ( D. M. Woodbury, J. K. Penry, and C. E. Pippenger, eds.). Raven Press. New York, pp. 405–413.Google Scholar
  70. 70.
    Alvin, J. D., and Bush, M. T., 1977, Anticonvulsants (J. A. Vida, ed.), Academic Press. New York, pp. 113–150.Google Scholar
  71. 71.
    Maynert, E. W., 1982, Antiepileptic Drugs, Second ed. ( D. M. Woodbury, J. K. Penry, and C. E. Pippenger, eds.), Raven Press, New York, pp. 319–327.Google Scholar
  72. 72.
    Tang, B. K., Inaba, T., and Kalow, W., 1977, Fed. Proc. 36: 966.Google Scholar
  73. 73.
    Schottelius, D. D., 1982, Antiepileptic Drugs, Second ed. ( D. M. Woodbury, J. K. Penry, C. E. Pippenger, eds.), Raven Press, New York, pp. 415–420.Google Scholar
  74. 74.
    RavrJonsen, A., Lundin, M., and Secher, 0., 1969, Acta Pharmacol. Toxicol. (Kbh.) 27:193201.Google Scholar
  75. 75.
    Pitlick, W., Painler, M., and Pippenger, C., 1978, Clin. Pharmacol. Ther. 23: 346–350.PubMedGoogle Scholar
  76. 76.
    Trimble, M., 1982, Antiepileptic Drug Therapy in Pediatrics (P. L. Morselli, J. K. Penry, and C. E. Pippenger, eds.), Raven Press, New York, pp. 201–217.Google Scholar
  77. 77.
    Wolf, S. M., and Forsythe, A., 1978, Advances in Epileptology (H. Meindardi and A. J. Rowans, eds.), Swets and Zeitlinger, Amsterdam.Google Scholar
  78. 78.
    Hollister, L. E., 1965, Ann. N.Y. Acad. Sci. 123: 342–353.PubMedGoogle Scholar
  79. 79.
    Mattson, R. H., Gallagher, B. B., Reynolds, E. H., and Glass, D., 1973, Arch. Neurol. 29: 7881Google Scholar
  80. 80.
    Liprik, I. E., and Cloyd, J. C.. 1982, Antiepileptic Drugs, Second ed. ( D. M. Woodbury, J. K. Penry. and C. E. Pippenger. eds.), Raven Press, New York. pp. 441–448.Google Scholar
  81. 81.
    Reynolds. E. H., 1974, Epilepsia 16: 319–352.Google Scholar
  82. 82.
    Stamp, T. C. B., 1974, Proc. R. Soc. Med. 67: 64–68.PubMedGoogle Scholar
  83. 83.
    Schmidt, R. P., and Wilder, B. J., 1968, Epilepsy, F. A. Davis, Philadelphia.Google Scholar
  84. 84.
    Bossi, L., 1983, Drug Therapy in Pediatrics (P. L. Morselli, C. E. Pippenger, and J. K. Penry, eds.), Raven Press, New York, pp. 37–46.Google Scholar
  85. 85.
    Shapiro, S., Hartz, S. C., Siskind, V., Mitchell, A. A., Stone, D., Rosenberg, L., Monson, R. R., and Heinonen, O. P., 1976, Lancet 1: 272–275.PubMedGoogle Scholar
  86. 86.
    Nakane, Y., Okuma, T., Takahashi, R., and Sato. Y., 1980, Epilepsia 21: 663–680.PubMedGoogle Scholar
  87. 87.
    Lindhout. D., Meinardi, H., and Barth, P. H. G., 1982, Epilepsy, Pregnancy and the Child (D. Janz. L. Bossi, M. Dam, H. Helge, A. Richens, and D. Schmidt, eds.), Raven Press, New York, pp. 275–281.Google Scholar
  88. 88.
    Richens, A., 1976. Anticonvulsant Drugs and Enzyme Induction, Associated Scientific Publishers, Amsterdam, pp. 3–12.Google Scholar
  89. 89.
    McDonald, M. G., and Robinson, D. S., 1968, J.A.M.A. 204: 97–100.Google Scholar
  90. 90.
    Powel, D. A., 1981, J. Pediatr. 98: 1001.Google Scholar
  91. 91.
    Bruni, J., Wilder, B. J., Perchalshi, R. J., Hanrond, E. J., and Villarreal, H. J., Neurology (N. Y.) 30: 94–97.Google Scholar
  92. 92.
    Kutt, H., and Paris-Kutt, H., 1982, Antiepileptic Drugs (D. M. Woodbury, J. K. Penry, and C. E. Pippenger, eds.), Raven Press, New York, pp. 329–340.Google Scholar
  93. 93.
    Rincham, R. W., Schottelius, D. D., 1982, Antiepileptic Drugs, Second ed. ( D. M. Woodbury, J. K. Penry, and C. E. Pippenger, eds.), Raven Press, New York, pp. 429–440.Google Scholar
  94. 94.
    Mattson, R. H., Cramer, V. A., Williamson, P. D., and Novelly, R. A., 1978. Ann. Neurol. 3: 20–25.PubMedGoogle Scholar
  95. 95.
    Biltz, H., 1908, Berl. Dtsch. Chem. Ges. 41: 1379–1383.Google Scholar
  96. 96.
    Putnam, T. J., and Merritt, H. H.. 1941, Arch. Neurol. 45: 505–516.Google Scholar
  97. 97.
    Toman, J. E. P., 1952, Pharmacology 4: 168–218.Google Scholar
  98. 98.
    Woodbury, D. M., 1969, Basic Mechanisms of the Epilepsies (H. H. Jasper, A. A. Ward, Jr., and A. Pope, eds.), Little Brown, Boston, pp. 647–681.Google Scholar
  99. 99.
    Woodbury, D. M., and Esplin, D. W., 1959, Res. Publ. Assoc. Res. Nerv. Ment. Dis. 37: 2456.Google Scholar
  100. 100.
    Woodbury, D. M., and Kemp, J. W., 1971, Psychiatr. Neurol. Neurochir. 74: 91–115.PubMedGoogle Scholar
  101. 101.
    Woodbury, D. M., 1982, Antiepileptic Drugs, Second ed. ( D. M. Woodbury, J. K. Penry, and C. E. Pippenger, eds.), Raven Press, New York, pp. 269–282.Google Scholar
  102. 102.
    Buchthal, R., Svensmark O., and Schiller, P. J., 1960, Arch. Neurol. 2: 624–630.PubMedGoogle Scholar
  103. 103.
    Kutt, H., 1971, Ann. N.Y. Acad. Sci. 179: 704–722.Google Scholar
  104. 104.
    Lund, L., 1974, Arch. Neurol. 31: 289–294.PubMedGoogle Scholar
  105. 105.
    Wilder, B. J., Ramsay, R. E.. Willmore, L. J., Feussner, G. G., Perchaliski, R. J., and Shumate, J. B., 1977, Ann. Neurol. 1: 511–518.PubMedGoogle Scholar
  106. 106.
    Goldberg, M. A., 1980, Adv. Neurol. 27: 323–337.Google Scholar
  107. 107.
    Glazko, A. J., 1972, Antiepileptic Drugs (D. M. Woodbury, J. K. Penry, and R. P. Schmidt). Raven Press, New York, pp. 103–112.Google Scholar
  108. 108.
    Kutt, H., Louis, S., and McDowell, F., 1968, Arch. Neurol. 18: 465–471.PubMedGoogle Scholar
  109. 109.
    Woodbury, D. M., and Swinyard, E. A.. 1972, Antiepileptic Drugs (D. M. Woodbury, J. K. Penry, and R. P. Schmidt), Raven Press, New York, pp. 113–123.Google Scholar
  110. 110.
    Noach, E. L., Woodbury, D. M., and Goodman, L. S., 1958, J. Pharmacol. Exp. Ther. 122: 301–314.PubMedGoogle Scholar
  111. 111.
    Livingston, S., 1966, Drug Therapy for Epilepsy, Charles C Thomas, Springfield, Illinois.Google Scholar
  112. 112.
    Loscalzo, A. E., 1945, J. Nerv. Ment. Dis. 101: 537–544.Google Scholar
  113. 113.
    DeLorenzo, R. J., 1983, Adv. Neurol. 34: 325–328.PubMedGoogle Scholar
  114. 114.
    Barany, E. H., and Stein-Jensen, E., 1946, Arch. Int. Pharmacodyn. Ther. 73: 1–47.PubMedGoogle Scholar
  115. 115.
    Esplin, D. W., and Laffan, R. J., 1957, Arch. Int. Pharmacodyn. Titer. 113: 189–202.Google Scholar
  116. 116.
    Toman, J. E., Loewe, S., and Goodman, L. S., 1947, Arch. Neurol. 58: 312–324.Google Scholar
  117. 117.
    Esplin, D. W., and Freston, J. W., 1960, J. Pharmacol. Exp. Titer. 130: 68–80.Google Scholar
  118. 118.
    Korey, S. R., 1951, Proc. Soc. Exp. Biol. Med. 76: 297–299.PubMedGoogle Scholar
  119. 119.
    Rosenberg, P., and Bartels, E., 1967, J. Pharmacol. Exp. Ther. 155: 532–544.PubMedGoogle Scholar
  120. 120.
    Aston, R., and Domino, E. F., 1961, Psychopharmacologia 2: 304–317.PubMedGoogle Scholar
  121. 121.
    Delgado, J. M., and Mihailovic, L., 1956, Ann. N.Y. Acad. Sci. 64: 644–666.PubMedGoogle Scholar
  122. 122.
    Blum, B., 1964, Arch. Int. Pharmacodyn. Ther. 149: 45–55.PubMedGoogle Scholar
  123. 123.
    Gangloff, H., and Monnier, M., 1957, Electroencephalogr. Clin. Neurophysiol. 9: 43–58.PubMedGoogle Scholar
  124. 124.
    Morrell, F., Bradley, W., and Ptashne, M., 1959, Neurology (Minneap.) 9: 492–498.Google Scholar
  125. 125.
    Toman, J. E. P., 1969, Basic Mechanisms of the Epilepsies (H. H. Jasper, A. A. Ward, and A. Pope, eds.), Little, Brown, Boston, pp. 682–688.Google Scholar
  126. 126.
    Schmidt, R. P., and Wilder, J., 1968, Epilepsy: Contemporary Neurology Series, F. A. Davis, Philadelphia.Google Scholar
  127. 127.
    Raines, A., and Standaert, F. G., 1967, J. Pharmacol. Exp. Ther. 156: 591–597.PubMedGoogle Scholar
  128. 128.
    Raines, A., and Standaert, F. G., 1966, J. Pharmacol. Exp. Ther. 153: 361–366.Google Scholar
  129. 129.
    Esplin, D. W., 1957, Pharmacol. Exp. Ther. 120: 301–323.Google Scholar
  130. 130.
    Rosenthal, J., 1969, J. Physiol. (Lond.) 203: 121–133.Google Scholar
  131. 131.
    Woodbury, D. M., 1955, J. Pharmacol. Exp. Ther. 115: 74–95.PubMedGoogle Scholar
  132. 132.
    Delgado-Escueta, A. V., and Horan, M. P., 1980, Adv. Neurol. 27: 277–298.Google Scholar
  133. 133.
    Gibbs, M., and Ng, K. T., 1976, Brain Res. Bull. 1: 203–208.PubMedGoogle Scholar
  134. 134.
    Lewin, E., and Bleck, V., 1971, Neurology (Minneap.) 21: 647–651.Google Scholar
  135. 135.
    Festoff, B., and Appel, S. H., 1968, J. Clin. Invest. 47: 2752–2758.PubMedGoogle Scholar
  136. 136.
    Wilensky, A. J., and Lowden, J. A., 1972, Life Sci. 11: 319–327.Google Scholar
  137. 137.
    Gutman, Y., and Boonyaviroj, P., 1977, Naunyn Schmiedebergs Arch. Pharmacol. 296:293296.Google Scholar
  138. 138.
    Kootstra, A., and Woodhouse, S. P., 1974, Proc. Univ. Otago, Med. School 52: 6–7.Google Scholar
  139. 139.
    Deupree, J. D., 1976, Neuropharmacology 15: 187–195.PubMedGoogle Scholar
  140. 140.
    Deupree, J. D., 1977, Epilepsia 18: 309–315.PubMedGoogle Scholar
  141. 141.
    Camay, L., and Grundfest, S., 1974, Neuropharmacology 13: 1097–1108.Google Scholar
  142. 142.
    Julien, R. M., and Halpern, L. M., 1970, J. Pharmacol. Exp. Ther. 175: 206–212.PubMedGoogle Scholar
  143. 143.
    Fertziger, A. P., Liuzzi, S. E., and Dunham, P. B., 1971. Brain Res. 33: 592–596.PubMedGoogle Scholar
  144. 144.
    Lipicky, R. J., Gilbert, D. L., and Stillman, I. M., 1972, Proc. Natl. Acad. Sci. U.S.A. 69: 1758–1760.PubMedGoogle Scholar
  145. 145.
    Johnston, D., and Ayala, G. F., 1975, Science 189: 1009–1011.PubMedGoogle Scholar
  146. 146.
    Swanson, P. D., and Crane, P. O., 1972, Biochem. Pharmacol. 211: 2899–2905.Google Scholar
  147. 147.
    Schwartz, J. R., and Vogel, W., 1977, Eur. J. Pharmacol. 44: 241–249.Google Scholar
  148. 148.
    DeWeer, P., 1980, Adv. Neurol. 27: 353–362.Google Scholar
  149. 149.
    Perry, J. G., McKinney, L., and DeWeer, P., 1978, Nature 272: 271–273.PubMedGoogle Scholar
  150. 150.
    Sohn, R. S., and Ferrendelli, J. A., 1973, J. Pharmacol. Exp. Ther. 185: 272–275.PubMedGoogle Scholar
  151. 151.
    Ferrendelli, J. A., and Kinscherf, D. A., 1977, Epilepsia 18: 331–336.PubMedGoogle Scholar
  152. 152.
    Yaari, Y., Pincus, J. H., and Argov, Z., 1977, Ann. Neurol. 1: 334–338.PubMedGoogle Scholar
  153. 153.
    Woodbury, D. M., 1980, Adv. Neurol. 27: 447–471.PubMedGoogle Scholar
  154. 154.
    Raabe, W., and Ayala, G. F., 1976, Brain Res. 105: 597–601.PubMedGoogle Scholar
  155. 155.
    Ayala, G. F., Lin, S., and Johnston, D., 1977, Brain Res. 121: 245–258.PubMedGoogle Scholar
  156. 156.
    Ferrendelli, J. A., 1980, Adv. Neural. 27: 429–433.Google Scholar
  157. 157.
    Ferrendelli, J. A., and Kinscherf, D. A., 1971, Epilepsia 18: 331–336.Google Scholar
  158. 158.
    DeLorenzo, R. J., 1981, Cell Calcium 2: 365–385.PubMedGoogle Scholar
  159. 159.
    DeLorenzo, R. J., 1982, Fed. Proc. 41: 2265–2272.PubMedGoogle Scholar
  160. 160.
    Bowling, A., and DeLorenzo, R. J., 1982, Science 216: 1247–1250.PubMedGoogle Scholar
  161. 161.
    Bowling, A. C., and DeLorenzo, R. J., 1982, Neurology (N.Y.) 32: A225.Google Scholar
  162. 162.
    Bowling, A. C., and DeLorenzo, R. J., 1982, Neurosci. Abstr. 8: 505.Google Scholar
  163. 163.
    Shah, D. S., Chambon, P., and Guidotti, A., 1981, Neuropharmacology 20: 1115–1119.PubMedGoogle Scholar
  164. 164.
    Burnham, W. M., Spero, L., Okazaki, M. M., and Medras, B. K., 1981, Can. J. Physiol. Pharmacol. 59: 402–407.PubMedGoogle Scholar
  165. 165.
    Randall, L. O., Schallek, W., Keise, G. A., Keith, E. F., and Bagdon, R. E., 1960, Pharmacol. Exp. Ther. 129: 163–171.Google Scholar
  166. 166.
    Killam, E. K., and Suria, A., 1980, Adv. Neurol. 27: 597–615.PubMedGoogle Scholar
  167. 167.
    Randall, L. O., and Schallek, W., 1968, Psychopharmacology. A Review of Progress (D. H. Efron, ed.), U.S. Government Printing Office, Washington, pp. 153–184.Google Scholar
  168. 168.
    Swinyard, A., and Castellion, A. W., 1966, J. Pharmacol. Exp. Ther. 151: 369–375.PubMedGoogle Scholar
  169. 169.
    Gastaut, H., Naquel, R., Poire, R., and Tassinari, C. A., 1965, Epilepsia 6: 167–182.PubMedGoogle Scholar
  170. 170.
    Jaffe, R., and Christoff, N. J., 1967, Electroencephalogr, Clin. Neurophysiol. 23: 96.Google Scholar
  171. 171.
    Tallman, J. F., Paul, S. M., Skolnick, P., and Gallager, D. W., 1980, Science 207: 274–281.PubMedGoogle Scholar
  172. 172.
    Mohler, H., and Dkada, T., 1977, Science 198: 849–851.PubMedGoogle Scholar
  173. 173.
    Taft, W. C., and DeLorenzo, R. J., 1984, Proc. Natl. Acad. Sci. U.S.A. 81: 3118–3122.PubMedGoogle Scholar
  174. 174.
    Taft, W. C., and DeLorenzo, R. J., Neurosci. Abstr. 9: 1040.Google Scholar
  175. 175.
    Perlstein, M. A., 1946, Arch. Neurol. Psychol. 55: 164.Google Scholar
  176. 176.
    Perlstein, M. A., and Andelman, M. B., 1946, J. Pediatr. 29: 20–40.PubMedGoogle Scholar
  177. 177.
    Withrow, C. D., 1980, Adv. Neurol. 27: 577–586.PubMedGoogle Scholar
  178. 178.
    Butler, T. C., Kuroiwa, Y., Waddel, W. J., and Poole, D. T., 1966, J. Pharmacol. Exp. Ther. 152: 62–66.PubMedGoogle Scholar
  179. 179.
    Chamerlin, H. R., Waddell, W. J., and Butler, T. C., 1965, Neurology (Minneap.) 15:449454.Google Scholar
  180. 180.
    Goodman, L. S., Toman, J. E. P., and Swinyard, E. S., 1946, Am. J. Med. 1: 213–228.Google Scholar
  181. 181.
    Jensen, B. N., 1962, Dan. Med. Bull. 9: 74–79.PubMedGoogle Scholar
  182. 182.
    Ferrendelli, J. A., and Kupferberg, H. J., 1980, Adv. Neurol. 27: 587–596.PubMedGoogle Scholar
  183. 183.
    Schindler, W., 1961, Chem. Abstr. 55: 1671.Google Scholar
  184. 184.
    Theobald, W., and Kunz, H. A., 1963, Arzneium. Forsch. 13: 122–125.Google Scholar
  185. 185.
    Suria, A., and Killam, E. K., 1980, Adv. Neural. 27: 563–575.Google Scholar
  186. 186.
    Julien, R. M., 1982, Antiepileptic Drugs, Second ed. ( D. M. Woodbury, J. K. Penry, and C. E. Pippenger, eds.), Raven Press, New York, pp. 543–548.Google Scholar
  187. 187.
    Rasmussen, P., and Rushede, J., 1970, Acta Neurol. Scand. 46: 385–408.PubMedGoogle Scholar
  188. 188.
    Ito, T., Hori, M., Yoshida, K., and Shimizu, M., 1977, Epilepsia 18: 63–71.PubMedGoogle Scholar
  189. 189.
    Krupp, P., 1969, Headache 9: 42–46.PubMedGoogle Scholar
  190. 190.
    Myllya, V. V., 1976, Eur. Neurol. 114: 97–107.Google Scholar
  191. 191.
    Kupferberg, H. J., 1980, Adv. Neurol. 27: 643–654.PubMedGoogle Scholar
  192. 192.
    Johnston, D., and Slater. G. E., 1982, Antiepileptic Drugs, Second ed. ( D. M. Woodbury, J. K. Penry, and C. E. Pippenger, eds.), Raven Press, New York, pp. 611–616.Google Scholar
  193. 193.
    Simler, S., Ciesielski, L., and Maitre, M., Randrianariosa H., and Mandel, P. 1973, Biochem. Pharmacol. 22: 1701–1708.PubMedGoogle Scholar
  194. 194.
    Slater, G. E., and Johnston, D., 1978, Epilepsia 19: 379–384.PubMedGoogle Scholar
  195. 195.
    Woodbury, D. M.. 1980, Adv. Neurol. 27: 617–634.PubMedGoogle Scholar
  196. 196.
    Koch, A., and Woodbury, D. M., 1958, J. Pharmacol. Exp. Ther. 122: 335–342.PubMedGoogle Scholar
  197. 197.
    Koch, A., and Woodbury, D. M., 1960, Am. J. Physiol. 198: 434–440.PubMedGoogle Scholar
  198. 198.
    Lennox, W. G., Gibbs, E. L., and Gibbs, F.A., 1939, J.A.M.A. 113: 1002–1003.Google Scholar
  199. 199.
    Forster, F. M., 1951, J.A.M.A. 145: 211–215.Google Scholar
  200. 200.
    Sibley, W. A., Tucker, H. J., and Randt, C. T., 1962, N. Engl. J. Med. 267: 332–336.PubMedGoogle Scholar
  201. 201.
    Rollo, I. M., 1965, The Pharmacological Basis of Therapeutics, Third ed. ( L. Goodman and A. Gilman, eds.), Macmillan, New York, pp. 1072–1095.Google Scholar
  202. 202.
    McQuarrie, I., Anderson, J. A., and Ziegler, M. R., 1942, J. Clin. Endocrinol. 2: 406–410.Google Scholar
  203. 203.
    Schneider, J., 1961, Epilepsia 2: 358–366.PubMedGoogle Scholar
  204. 204.
    Miribel, J., and Poirier, F., 1961, Epilepsia 2: 345–353.PubMedGoogle Scholar
  205. 205.
    Roberts, E., 1963. Nutr. Rev. 21: 161–165.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1985

Authors and Affiliations

  • Robert J. DeLorenzo
    • 1
  • Larry H. Dashefsky
    • 1
  1. 1.Department of NeurologyYale University School of MedicineNew HavenUSA

Personalised recommendations